Frontage announces that Dr. Philip Doren has joined Frontage as the President of Clinical Services
Today, Frontage announces that Dr. Philip Doren has joined Frontage as the President of Clinical Services. He will help Frontage to evaluate and secure early clinical and biometric opportunities and develop relationships with strategic partners to expand our services in key areas of support.
Dr. Doren has over 20 years of experience in developing and managing external partnerships in the CRO industry. His most recent position was with Everest Clinical Research where he served as General Manager and Vice President of Clinical Operations and was responsible for development of the biometrics-focused business and established the Clinical Services business. Prior to Everest, he served as Global Vice President of Biometrics at SynteractHCR (2012-2015); Vice President, Clinical Data Analysis, and Reporting Organization at Covance (2008 – 2012); Vice President, Head of Biostatistics – North America, Quintiles (2003 – 2008).
Philip received his M.S. and Ph.D. in quantitative genetics from Texas A&M University.
“We have committed to build up one of the best CRO companies. I am confident that Philip’s experience and abilities will be great assets to our company and our clients, and his participation will deliver significant contributions to our rapidly growing business,” stated Dr. Song Li, CEO of Frontage.